Frontiers in Digital Health (Sep 2023)

Retrospective observational study of a novel smartphone app on the management of patients with mild cognitive impairment or mild dementia

  • Reo Hamaguchi,
  • Yoshihiro Hirokawa,
  • Hirotsugu Takahashi,
  • Tsuyoshi Hachiya,
  • Haruna Kawano,
  • Shuji Isotani,
  • Emi Ito,
  • Nobuhiro Handa,
  • Ryozo Saito,
  • Shigeo Horie,
  • Hisamitsu Ide

DOI
https://doi.org/10.3389/fdgth.2023.1243253
Journal volume & issue
Vol. 5

Abstract

Read online

IntroductionIn this study, we aimed to evaluate the feasibility, utility, and potential effects of LQ-M/D App, a smartphone application developed by Life Quest Inc., Tokyo, Japan, for patients with mild cognitive impairment (MCI) and mild dementia. The app incorporates cognitive and physical exercise training, lifestyle habit acquisition features, and a continuity improvement feature added in the post-update version to enhance user engagement. The continuity improvement feature includes the optimization of training content, and disease education, and enables family monitoring via a family app.MethodsA retrospective analysis was conducted on app usage, cognitive and exercise training implementation and interruptions, questionnaire response rates, and cognitive assessments in a single institution. A total of 20 patients used the app, with 10 patients using the pre-update version without the continuity improvement feature, and the other 10 patients using the post-update version with the continuity improvement feature.Results and ConclusionThe results demonstrated that the LQ-M/D App could be effectively used by the study population, and the continuity improvement feature positively influenced app usage in several aspects. Although a potential association between app usage and cognitive ability was suggested, the scatter in the data points warrants cautious interpretation. Limitations of the study included a small sample size, a single institution setting, and the retrospective nature of the study. In the future, a randomized controlled trial design using a larger sample size and multiple institutions to further evaluate the effectiveness of LQ-M/D App in managing MCI and mild dementia should be performed.

Keywords